Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 105 resultados

NR2F6-AIM: NR2F6 Blockade as Adoptive Immune Cell Therapy for Metastatic Melanoma MEDIZINISCHE UNIVERSITAT INNSBRUCK tramitó un HORIZON EUROPE: ERC-2024-POC Melanoma cases and deaths are expected to increase in the coming years, representing a significant burden for the European economy and healt...
2024-09-01 - 2026-02-28 | Financiado

NR2F6-AIM: NR2F6 Blockade as Adoptive Immune Cell Therapy for Metastatic Melanoma MEDIZINISCHE UNIVERSITAT INNSBRUCK tramitó un HORIZON EUROPE: ERC-2024-POC Melanoma cases and deaths are expected to increase in the coming years, representing a significant burden for the European economy and healt...
2024-08-09 - 2026-02-28 | Financiado

T-RAFIC: Training network for tracking and controlling therapeutic immune cells in cancer Cancer immunotherapies have been established in a growing number of clinical indications and the pace of development is massively accelerat...
2024-07-16 - 2029-03-31 | Financiado

PICKED: PersonalIzed medicine in Chronic KidnEy Disease MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 In 2017, on a world scale the total number of individuals with chronic kidney disease, acute kidney injury, and those on renal replacement t...
2024-06-26 - 2028-09-30 | Financiado

PROMOTE: PRostate cancer OMics Oriented inTErvention PROMOTE focuses on multidisciplinary education of doctoral candidates (DCs) in -omics and artificial intelligence (AI) mediated intervention...
2024-06-24 - 2028-08-31 | Financiado

EBRAINS 2.0: EBRAINS 2.0 A Research Infrastructure to Advance Neuroscience and Brain Health MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un HORIZON EUROPE: HORIZON-INFRA-2022-SERV-B-01 EBRAINS is a collaborative European Research Infrastructure designed to advance and accelerate progress in neuroscience and brain health. Th...
2023-12-14 - 2026-12-31 | Financiado

GRASP-SYNERGY: Developments of the Generalized Retrieval of Atmospheric and Surface Properties for the synergy of d... MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un HORIZON EUROPE: HORIZON-MSCA-2022-SE-01 The GRASP-SYNERGY proposal is to make an international and inter-sectorial network of organizations working together including scientists an...
2023-10-16 - 2027-11-30 | Financiado

ONCOSCREEN: A European shield against colorectal cancer based on novel, more precise and affordable risk-based s... MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 With Colorectal Cancer (CRC) being accountable for 12.4% of all deaths due to cancer, and with only 14% of EU citizens participating in scre...
2022-11-28 - 2026-12-31 | Financiado

MERIT: Central Bohemia Mobility Programme for Excellence in Research Innovation and Technology MERIT will be a 5-year regional programme for 30 incoming postdoctoral researchers from all over the world. It is a joint initiative of the...
2022-10-10 - 2027-12-31 | Financiado

CAR-T-uning: Chimeric Antigen Receptor (CAR) T Cell Therapy For Solid Tumors MEDIZINISCHE UNIVERSITAT INNSBRUCK tramitó un HORIZON EUROPE: ERC-2022-POC1 CAR-T(uning) will assess the technical and commercial feasibility of an improved and broadly applicable chimeric antigen receptor T-cell (CA...
2022-07-08 - 2024-02-29 | Financiado

PARC: Partnership for the Assessment of Risks from Chemicals MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-03 PARC is an EU-wide research and innovation partnership programme to support EU and national chemical risk assessment and risk management bod...
2022-05-24 - 2029-04-30 | Financiado

MEGI CD: Metabolic Gut Inflammation in Crohn's disease MEDIZINISCHE UNIVERSITAT INNSBRUCK tramitó un HORIZON EUROPE: ERC-2021-STG The rising incidence of inflammatory bowel diseases such as Crohn?s disease (CD) has become a global health care issue in the 21st century....
2022-03-08 - 2027-03-31 | Financiado

ALTERNATIVE: environmentAL Toxicity chEmical mixtuRes through aN innovative platform based on aged cardiac tissue... MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un H2020: H2020-LC-GD-2020 ALTERNATIVE will develop an innovative platform able to detect the cardiotoxicity of chemicals and their bio-transformation products. The no...
2021-09-02 - 2025-03-31 | Financiado

PRISMAP: The European medical isotope programme Production of high purity isotopes by mass separation MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un H2020: H2020-INFRAIA-2018-2020 PRISMAP - The European medical isotope programme: Production of high purity isotopes by mass separation proposes to federate a consortium of...
2021-07-07 - 2025-04-30 | Financiado

ATMO-ACCESS: Solutions for Sustainable Access to Atmospheric Research Facilities MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un H2020: H2020-INFRAIA-2018-2020 ATMO-ACCESS is the organized response of distributed atmospheric research facilities for developing a pilot for a new model of Integrating A...
2021-03-12 - 2025-03-31 | Financiado

TTV GUIDE TX: PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION A RANDOM... MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un H2020: H2020-SC1-BHC-2018-2020 Challenge: End stage renal disease (ESRD) causes high socioeconomic burden for citizens and the healthcare system in Europe. Kidney transpla...
2021-02-02 - 2026-04-30 | Financiado

INCITE: Immune Niches for Cancer ImmunoTherapy Enhancement MEDIZINISCHE UNIVERSITAT INNSBRUCK participó en un H2020: H2020-FETOPEN-2018-2020 Cancer is rapidly becoming the most frequent cause of morbidity and mortality in the EU, accounting for a quarter of all deaths in EU. Witho...
2020-12-21 - 2025-04-30 | Financiado

MUI